TUESDAY, Nov. 2, 2021 (HealthDay News) — U.S. health officials say they’re keeping close watch on a ‘Delta plus’ variant that’s been detected in at least eight states. While the AY.4.2 “sub-lineage” of Delta may spread faster than the original variant, there’s no evidence that it causes more severe illness,Continue Reading

TUESDAY, Nov. 2, 2021 (HealthDay News) — Contaminated water is the leading cause of large-scale outbreaks of infectious diseases that can be transmitted from animals to people, researchers say. These health threats are called zoonotic infectious diseases, and recent outbreaks include COVID-19 and Ebola. “In the age of COVID-19, itContinue Reading

MONDAY, Nov. 1, 2021 (HealthDay News) — An experimental Breathalyzer-type test can detect COVID-19 within seconds and could become a noninvasive, faster alternative to nasal swab tests, researchers report. COVID-19 infection produces a distinct breath print from the interaction of oxygen, nitric oxide and ammonia in the body, the investigatorsContinue Reading

FRIDAY, Oct. 29, 2021 (HealthDay News) — Coronavirus cases have plunged by 60% since mid-September’s Delta-driven peak, U.S. health officials said earlier this week. But with winter on the way, they warned that Americans still need to protect themselves and others against COVID-19. “We are now heading in the rightContinue Reading

FRIDAY, Oct. 29, 2021 (HealthDay News) — There are two ways that HIV patients’ bodies can keep the virus under control after they stop antiretroviral therapy, a new study shows. The findings could point to ways to help people with HIV keep the virus in remission without having to keepContinue Reading

THURSDAY, Oct. 28, 2021 (HealthDay News) — A cheap and widely available antidepressant drug called fluvoxamine may reduce COVID-19 patients’ risk of serious illness requiring hospitalization, according to a new study. The trial included almost 1,500 unvaccinated outpatients in Brazil. All of the patients tested positive for infection with SARS-CoV-2Continue Reading